Adaptimmune Therapeutics plc
Q4 2021 Earnings Call Transcript

Published:

  • Disclaimer*:
    This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide.
  • Operator:
    00
  • Juli Miller:
    00
  • Adrian Rawcliffe:
    01
  • Operator:
    10
  • Marc Frahm:
    10
  • Adrian Rawcliffe:
    10
  • Dennis Williams:
    10
  • Marc Frahm:
    11
  • Dennis Williams:
    12
  • Marc Frahm:
    13
  • Adrian Rawcliffe:
    13
  • Operator:
    13
  • Unidentified Analyst:
    13
  • Adrian Rawcliffe:
    13
  • Elliot Norry:
    14
  • Unidentified Analyst:
    16
  • Adrian Rawcliffe:
    16
  • Operator:
    16
  • Nick Abbott:
    16
  • Adrian Rawcliffe:
    16
  • John Lunger:
    17
  • Nick Abbott:
    17
  • Adrian Rawcliffe:
    18
  • Dennis Williams:
    18
  • Nick Abbott:
    19
  • Dennis Williams:
    20
  • Nick Abbott:
    21
  • Adrian Rawcliffe:
    21
  • Operator:
    21
  • Unidentified Analyst:
    21
  • Adrian Rawcliffe:
    21
  • Unidentified Analyst:
    22
  • John Lunger:
    22
  • Unidentified Analyst:
    24
  • Adrian Rawcliffe:
    24
  • Operator:
    24
  • Unidentified Analyst:
    24
  • Adrian Rawcliffe:
    24
  • Helen Tayton-Martin:
    24
  • Unidentified Analyst:
    25
  • Adrian Rawcliffe:
    25
  • Operator:
    25
  • Unidentified Analyst:
    25
  • Adrian Rawcliffe:
    25
  • Dennis Williams:
    26
  • Unidentified Analyst:
    27
  • Adrian Rawcliffe:
    27
  • Operator:
    27
  • Unidentified Analyst:
    27
  • Adrian Rawcliffe:
    27
  • Karen Miller:
    28
  • Unidentified Analyst:
    28
  • Gavin Wood:
    28
  • Unidentified Analyst:
    28
  • Adrian Rawcliffe:
    28
  • Operator:
    28
  • Adrian Rawcliffe:
    29
  • Operator:
    29

Other Adaptimmune Therapeutics plc earnings call transcripts: